Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers in 2025, and is the second most common cancer in men behind skin cancer, according to the American Cancer ...
MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
SurvivorNet on MSN
Prostate cancer screening: Get the actual guidelines for men, why doctors don’t agree, and what you need to know to make decisions
A new Super Bowl Sunday ad starring legendary NFL players aims to boost prostate cancer awareness. Using humor and famous ...
Researchers analyze prostate cancer incidence over 20 years in men aged 45-70 years without prostate cancer and identify ...
Two brothers who had prostate cancer surgery within weeks of each other are calling on men with a family history of the ...
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
MedPage Today on MSN
'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer
But an association with improved overall survival failed to reach statistical significance ...
Steve, Jim, Andy and Tim Hastings found out they were battling the same disease within 6 months of one another ...
“Talking about health should never be awkward,” the former NFL tight end tells PEOPLE ...
Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...
Unfortunately, you’re not able to donate blood today. Not until you’re cancer-free for at least a year. Just on the outside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results